|
Volumn 7, Issue 2, 2006, Pages 95-97
|
Almotriptan in the acute treatment of migraine in patients 11-17 years old: An open-label pilot study of efficacy and safety
|
Author keywords
Adolescent; Almotriptan; Children; Migraine; Triptan
|
Indexed keywords
ALMOTRIPTAN;
SEROTONIN AGONIST;
TRYPTAMINE DERIVATIVE;
ADOLESCENT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
MALE;
MIGRAINE;
MIGRAINE WITH AURA;
MIGRAINE WITHOUT AURA;
MUSCULOSKELETAL STIFFNESS;
OPEN STUDY;
PHYSICAL DISABILITY;
PILOT STUDY;
PRIORITY JOURNAL;
SCHOOL CHILD;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
CHILD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DISABILITY;
METHODOLOGY;
PAIN ASSESSMENT;
ADOLESCENT;
CHILD;
CLINICAL TRIALS;
DISABILITY EVALUATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MIGRAINE DISORDERS;
PAIN MEASUREMENT;
PILOT PROJECTS;
SEROTONIN AGONISTS;
TREATMENT OUTCOME;
TRYPTAMINES;
|
EID: 33745994262
PISSN: 11292369
EISSN: 11292377
Source Type: Journal
DOI: 10.1007/s10194-006-0288-0 Document Type: Article |
Times cited : (21)
|
References (10)
|